ALINIA

LOE Approaching

nitazoxanide

NDAORALFOR SUSPENSIONPriority Review
Approved
Nov 2002
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3

Mechanism of Action

12.1 Mechanism of Action Nitazoxanide is an antiprotozoal [ )]. 12.3 Pharmacokinetics Absorption Single Dosing : Following oral administration of ALINIA Tablets or Oral Suspension, the parent drug, nitazoxanide, is not detected in plasma. The pharmacokinetic parameners of the metabolites,…

Clinical Trials (3)

NCT05453916Phase 1/2Withdrawn

Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation

Started Jul 2022
NCT04459286Phase 2Terminated

The Nitazoxanide Plus Atazanavir for COVID-19 Study

Started Oct 2020
57 enrolled
Covid-19
NCT04348409N/ACompleted

Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19

Started May 2020